Truist Securities Maintains Buy on American Healthcares, Raises Price Target to $27
Portfolio Pulse from Benzinga Newsdesk
Truist Securities has maintained a Buy rating on American Healthcares (NYSE:AHR) and increased the price target from $22 to $27, indicating confidence in the company's future performance.
September 20, 2024 | 2:42 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Truist Securities has reaffirmed its Buy rating on American Healthcares and raised the price target from $22 to $27, suggesting a positive outlook for the company's stock.
The increase in the price target from $22 to $27 by Truist Securities indicates a strong positive sentiment towards American Healthcares' future performance. This is likely to boost investor confidence and could lead to a short-term increase in the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100